Dr Saban Secmeler
Klinischer Onkologe/-in
Dr. Saban Secmeler is a medical professional known for his contribution to cancer research, particularly a significant study on the impact of body mass index on the recurrence and survival rates in early-stage colorectal cancer.
Standort
Dr. Saban Secmeler has made significant contributions to the field of cancer research. He was notably involved in a crucial study assessing 'The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer', published in the renowned Journal of Cancer Research and Therapeutics. This retrospective study, conducted from 1999 to 2016, analyzed the treatment outcomes of patients with colorectal cancer. It concluded that a higher body mass index corresponded to an increased risk of recurrence, particularly in Stage III patients, with most recurrences occurring locally.